Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
CAR T-cell therapy is a cancer treatment that uses a patient’s own immune system cells, called T cells, after these cells have been modified to better recognize and kill the patient’s cancer. The T cells are engineered in the laboratory and then expanded to large numbers and infused back into the patient. This type of treatment transfers an immune system into the patient that is capable of immediately killing the cancer. CAR stands for chimeric antigen receptor, which represents the genetically engineered portion of the T cell. The CAR part of the T cell contains proteins that allow the T cells to recognize the specific cancer cells as well as become highly activated to kill the cancer cells.
Based on the Chimeric Antigen Receptor (CAR) T-Cell Therapy market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Chimeric Antigen Receptor (CAR) T-Cell Therapy market covered in Chapter 5:
Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
Celyad SA
Celgene Corp.
F. Hoffman La Roche AG
Transgene SA
Juno Therapeutics Inc. (A Celgene Company)
Shire Pharmaceuticals Inc.
Eureka Therapeutics Inc.
Cellectis
Formula Pharmaceuticals Inc.
Avacta Life Sciences Ltd.
Gilead Sciences
iCell Gene Therapeutics
Bellicum Phamaceuticals
Amgen
Servier Laboratories
Noile-Immune Biotech
Puretech Health
Editas Medicine Inc.
Medimmune Llc/Astrazeneca
Bluebird Bio
Mustang Bio Inc.
Novartis AG
Protheragen Inc.
Takeda Pharmaceuticals
In Chapter 6, on the basis of types, the Chimeric Antigen Receptor (CAR) T-Cell Therapy market from 2015 to 2025 is primarily split into:
Acute Lymphoblastic Leukemia (ALL)
Advanced Lymphomas
Others
In Chapter 7, on the basis of applications, the Chimeric Antigen Receptor (CAR) T-Cell Therapy market from 2015 to 2025 covers:
Children
Adult
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Based on the Chimeric Antigen Receptor (CAR) T-Cell Therapy market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Chimeric Antigen Receptor (CAR) T-Cell Therapy market covered in Chapter 5:
Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
Celyad SA
Celgene Corp.
F. Hoffman La Roche AG
Transgene SA
Juno Therapeutics Inc. (A Celgene Company)
Shire Pharmaceuticals Inc.
Eureka Therapeutics Inc.
Cellectis
Formula Pharmaceuticals Inc.
Avacta Life Sciences Ltd.
Gilead Sciences
iCell Gene Therapeutics
Bellicum Phamaceuticals
Amgen
Servier Laboratories
Noile-Immune Biotech
Puretech Health
Editas Medicine Inc.
Medimmune Llc/Astrazeneca
Bluebird Bio
Mustang Bio Inc.
Novartis AG
Protheragen Inc.
Takeda Pharmaceuticals
In Chapter 6, on the basis of types, the Chimeric Antigen Receptor (CAR) T-Cell Therapy market from 2015 to 2025 is primarily split into:
Acute Lymphoblastic Leukemia (ALL)
Advanced Lymphomas
Others
In Chapter 7, on the basis of applications, the Chimeric Antigen Receptor (CAR) T-Cell Therapy market from 2015 to 2025 covers:
Children
Adult
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
1 MARKET OVERVIEW
1.1 Product Definition and Market Characteristics
1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
5.1.1 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Company Profile
5.1.2 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Business Overview
5.1.3 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.2 Celyad SA
5.2.1 Celyad SA Company Profile
5.2.2 Celyad SA Business Overview
5.2.3 Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.3 Celgene Corp.
5.3.1 Celgene Corp. Company Profile
5.3.2 Celgene Corp. Business Overview
5.3.3 Celgene Corp. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Celgene Corp. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.4 F. Hoffman La Roche AG
5.4.1 F. Hoffman La Roche AG Company Profile
5.4.2 F. Hoffman La Roche AG Business Overview
5.4.3 F. Hoffman La Roche AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 F. Hoffman La Roche AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.5 Transgene SA
5.5.1 Transgene SA Company Profile
5.5.2 Transgene SA Business Overview
5.5.3 Transgene SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Transgene SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.6 Juno Therapeutics Inc. (A Celgene Company)
5.6.1 Juno Therapeutics Inc. (A Celgene Company) Company Profile
5.6.2 Juno Therapeutics Inc. (A Celgene Company) Business Overview
5.6.3 Juno Therapeutics Inc. (A Celgene Company) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Juno Therapeutics Inc. (A Celgene Company) Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.7 Shire Pharmaceuticals Inc.
5.7.1 Shire Pharmaceuticals Inc. Company Profile
5.7.2 Shire Pharmaceuticals Inc. Business Overview
5.7.3 Shire Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Shire Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.8 Eureka Therapeutics Inc.
5.8.1 Eureka Therapeutics Inc. Company Profile
5.8.2 Eureka Therapeutics Inc. Business Overview
5.8.3 Eureka Therapeutics Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Eureka Therapeutics Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.9 Cellectis
5.9.1 Cellectis Company Profile
5.9.2 Cellectis Business Overview
5.9.3 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.10 Formula Pharmaceuticals Inc.
5.10.1 Formula Pharmaceuticals Inc. Company Profile
5.10.2 Formula Pharmaceuticals Inc. Business Overview
5.10.3 Formula Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Formula Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.11 Avacta Life Sciences Ltd.
5.11.1 Avacta Life Sciences Ltd. Company Profile
5.11.2 Avacta Life Sciences Ltd. Business Overview
5.11.3 Avacta Life Sciences Ltd. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Avacta Life Sciences Ltd. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.12 Gilead Sciences
5.12.1 Gilead Sciences Company Profile
5.12.2 Gilead Sciences Business Overview
5.12.3 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.13 iCell Gene Therapeutics
5.13.1 iCell Gene Therapeutics Company Profile
5.13.2 iCell Gene Therapeutics Business Overview
5.13.3 iCell Gene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 iCell Gene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.14 Bellicum Phamaceuticals
5.14.1 Bellicum Phamaceuticals Company Profile
5.14.2 Bellicum Phamaceuticals Business Overview
5.14.3 Bellicum Phamaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Bellicum Phamaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.15 Amgen
5.15.1 Amgen Company Profile
5.15.2 Amgen Business Overview
5.15.3 Amgen Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Amgen Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.16 Servier Laboratories
5.16.1 Servier Laboratories Company Profile
5.16.2 Servier Laboratories Business Overview
5.16.3 Servier Laboratories Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Servier Laboratories Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.17 Noile-Immune Biotech
5.17.1 Noile-Immune Biotech Company Profile
5.17.2 Noile-Immune Biotech Business Overview
5.17.3 Noile-Immune Biotech Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Noile-Immune Biotech Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.18 Puretech Health
5.18.1 Puretech Health Company Profile
5.18.2 Puretech Health Business Overview
5.18.3 Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.19 Editas Medicine Inc.
5.19.1 Editas Medicine Inc. Company Profile
5.19.2 Editas Medicine Inc. Business Overview
5.19.3 Editas Medicine Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Editas Medicine Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.20 Medimmune Llc/Astrazeneca
5.20.1 Medimmune Llc/Astrazeneca Company Profile
5.20.2 Medimmune Llc/Astrazeneca Business Overview
5.20.3 Medimmune Llc/Astrazeneca Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.20.4 Medimmune Llc/Astrazeneca Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.21 Bluebird Bio
5.21.1 Bluebird Bio Company Profile
5.21.2 Bluebird Bio Business Overview
5.21.3 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.21.4 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.22 Mustang Bio Inc.
5.22.1 Mustang Bio Inc. Company Profile
5.22.2 Mustang Bio Inc. Business Overview
5.22.3 Mustang Bio Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.22.4 Mustang Bio Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.23 Novartis AG
5.23.1 Novartis AG Company Profile
5.23.2 Novartis AG Business Overview
5.23.3 Novartis AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.23.4 Novartis AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.24 Protheragen Inc.
5.24.1 Protheragen Inc. Company Profile
5.24.2 Protheragen Inc. Business Overview
5.24.3 Protheragen Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.24.4 Protheragen Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.25 Takeda Pharmaceuticals
5.25.1 Takeda Pharmaceuticals Company Profile
5.25.2 Takeda Pharmaceuticals Business Overview
5.25.3 Takeda Pharmaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.25.4 Takeda Pharmaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Market Share by Types (2015-2020)
6.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Types (2015-2020)
6.1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Types (2015-2020)
6.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast by Types (2020-2025)
6.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Price and Growth Rate of Acute Lymphoblastic Leukemia (ALL)
6.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Price and Growth Rate of Advanced Lymphomas
6.3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Price and Growth Rate of Others
6.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Acute Lymphoblastic Leukemia (ALL) Market Revenue and Sales Forecast (2020-2025)
6.4.2 Advanced Lymphomas Market Revenue and Sales Forecast (2020-2025)
6.4.3 Others Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Market Share by Applications (2015-2020)
7.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Applications (2015-2020)
7.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast by Applications (2020-2025)
7.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Sales and Growth Rate of Children (2015-2020)
7.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Sales and Growth Rate of Adult (2015-2020)
7.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Children Market Revenue and Sales Forecast (2020-2025)
7.4.2 Adult Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales by Regions (2015-2020)
8.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue by Regions (2015-2020)
8.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast by Regions (2020-2025)
9 NORTH AMERICA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
9.3 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
9.4 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Country
9.6.1 U.S. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
9.6.2 Canada Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
9.6.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10 EUROPE CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
10.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
10.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Country
10.6.1 Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10.6.2 United Kingdom Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10.6.3 France Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10.6.4 Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10.6.5 Spain Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10.6.6 Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
11 ASIA-PACIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Country
11.6.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
11.6.2 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
11.6.3 South Korea Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
11.6.4 Australia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
11.6.5 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
12 SOUTH AMERICA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
12.3 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
12.4 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Country
12.6.1 Brazil Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
12.6.2 Argentina Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
12.6.3 Columbia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
13 MIDDLE EAST AND AFRICA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Country
13.6.1 UAE Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
13.6.2 Egypt Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
13.6.3 South Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
1.1 Product Definition and Market Characteristics
1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis
2. MARKET DYNAMICS
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact
3 ASSOCIATED INDUSTRY ASSESSMENT
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain
4 MARKET COMPETITIVE LANDSCAPE
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans
5 ANALYSIS OF LEADING COMPANIES
5.1 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.)
5.1.1 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Company Profile
5.1.2 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Business Overview
5.1.3 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.2 Celyad SA
5.2.1 Celyad SA Company Profile
5.2.2 Celyad SA Business Overview
5.2.3 Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Celyad SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.3 Celgene Corp.
5.3.1 Celgene Corp. Company Profile
5.3.2 Celgene Corp. Business Overview
5.3.3 Celgene Corp. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Celgene Corp. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.4 F. Hoffman La Roche AG
5.4.1 F. Hoffman La Roche AG Company Profile
5.4.2 F. Hoffman La Roche AG Business Overview
5.4.3 F. Hoffman La Roche AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 F. Hoffman La Roche AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.5 Transgene SA
5.5.1 Transgene SA Company Profile
5.5.2 Transgene SA Business Overview
5.5.3 Transgene SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Transgene SA Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.6 Juno Therapeutics Inc. (A Celgene Company)
5.6.1 Juno Therapeutics Inc. (A Celgene Company) Company Profile
5.6.2 Juno Therapeutics Inc. (A Celgene Company) Business Overview
5.6.3 Juno Therapeutics Inc. (A Celgene Company) Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Juno Therapeutics Inc. (A Celgene Company) Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.7 Shire Pharmaceuticals Inc.
5.7.1 Shire Pharmaceuticals Inc. Company Profile
5.7.2 Shire Pharmaceuticals Inc. Business Overview
5.7.3 Shire Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Shire Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.8 Eureka Therapeutics Inc.
5.8.1 Eureka Therapeutics Inc. Company Profile
5.8.2 Eureka Therapeutics Inc. Business Overview
5.8.3 Eureka Therapeutics Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Eureka Therapeutics Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.9 Cellectis
5.9.1 Cellectis Company Profile
5.9.2 Cellectis Business Overview
5.9.3 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Cellectis Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.10 Formula Pharmaceuticals Inc.
5.10.1 Formula Pharmaceuticals Inc. Company Profile
5.10.2 Formula Pharmaceuticals Inc. Business Overview
5.10.3 Formula Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Formula Pharmaceuticals Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.11 Avacta Life Sciences Ltd.
5.11.1 Avacta Life Sciences Ltd. Company Profile
5.11.2 Avacta Life Sciences Ltd. Business Overview
5.11.3 Avacta Life Sciences Ltd. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Avacta Life Sciences Ltd. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.12 Gilead Sciences
5.12.1 Gilead Sciences Company Profile
5.12.2 Gilead Sciences Business Overview
5.12.3 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Gilead Sciences Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.13 iCell Gene Therapeutics
5.13.1 iCell Gene Therapeutics Company Profile
5.13.2 iCell Gene Therapeutics Business Overview
5.13.3 iCell Gene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 iCell Gene Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.14 Bellicum Phamaceuticals
5.14.1 Bellicum Phamaceuticals Company Profile
5.14.2 Bellicum Phamaceuticals Business Overview
5.14.3 Bellicum Phamaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Bellicum Phamaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.15 Amgen
5.15.1 Amgen Company Profile
5.15.2 Amgen Business Overview
5.15.3 Amgen Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Amgen Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.16 Servier Laboratories
5.16.1 Servier Laboratories Company Profile
5.16.2 Servier Laboratories Business Overview
5.16.3 Servier Laboratories Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Servier Laboratories Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.17 Noile-Immune Biotech
5.17.1 Noile-Immune Biotech Company Profile
5.17.2 Noile-Immune Biotech Business Overview
5.17.3 Noile-Immune Biotech Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Noile-Immune Biotech Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.18 Puretech Health
5.18.1 Puretech Health Company Profile
5.18.2 Puretech Health Business Overview
5.18.3 Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 Puretech Health Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.19 Editas Medicine Inc.
5.19.1 Editas Medicine Inc. Company Profile
5.19.2 Editas Medicine Inc. Business Overview
5.19.3 Editas Medicine Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Editas Medicine Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.20 Medimmune Llc/Astrazeneca
5.20.1 Medimmune Llc/Astrazeneca Company Profile
5.20.2 Medimmune Llc/Astrazeneca Business Overview
5.20.3 Medimmune Llc/Astrazeneca Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.20.4 Medimmune Llc/Astrazeneca Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.21 Bluebird Bio
5.21.1 Bluebird Bio Company Profile
5.21.2 Bluebird Bio Business Overview
5.21.3 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.21.4 Bluebird Bio Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.22 Mustang Bio Inc.
5.22.1 Mustang Bio Inc. Company Profile
5.22.2 Mustang Bio Inc. Business Overview
5.22.3 Mustang Bio Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.22.4 Mustang Bio Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.23 Novartis AG
5.23.1 Novartis AG Company Profile
5.23.2 Novartis AG Business Overview
5.23.3 Novartis AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.23.4 Novartis AG Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.24 Protheragen Inc.
5.24.1 Protheragen Inc. Company Profile
5.24.2 Protheragen Inc. Business Overview
5.24.3 Protheragen Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.24.4 Protheragen Inc. Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
5.25 Takeda Pharmaceuticals
5.25.1 Takeda Pharmaceuticals Company Profile
5.25.2 Takeda Pharmaceuticals Business Overview
5.25.3 Takeda Pharmaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.25.4 Takeda Pharmaceuticals Chimeric Antigen Receptor (CAR) T-Cell Therapy Products Introduction
6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES
6.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Market Share by Types (2015-2020)
6.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Types (2015-2020)
6.1.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price by Types (2015-2020)
6.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast by Types (2020-2025)
6.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Price and Growth Rate of Acute Lymphoblastic Leukemia (ALL)
6.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Price and Growth Rate of Advanced Lymphomas
6.3.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Price and Growth Rate of Others
6.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Acute Lymphoblastic Leukemia (ALL) Market Revenue and Sales Forecast (2020-2025)
6.4.2 Advanced Lymphomas Market Revenue and Sales Forecast (2020-2025)
6.4.3 Others Market Revenue and Sales Forecast (2020-2025)
7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS
7.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Market Share by Applications (2015-2020)
7.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Market Share by Applications (2015-2020)
7.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast by Applications (2020-2025)
7.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Sales and Growth Rate of Children (2015-2020)
7.3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue, Sales and Growth Rate of Adult (2015-2020)
7.4 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Children Market Revenue and Sales Forecast (2020-2025)
7.4.2 Adult Market Revenue and Sales Forecast (2020-2025)
8 MARKET ANALYSIS AND FORECAST, BY REGIONS
8.1 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales by Regions (2015-2020)
8.2 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue by Regions (2015-2020)
8.3 Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast by Regions (2020-2025)
9 NORTH AMERICA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS
9.1 Market Overview and Prospect Analysis
9.2 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
9.3 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
9.4 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Country
9.6.1 U.S. Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
9.6.2 Canada Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
9.6.3 Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10 EUROPE CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS
10.1 Market Overview and Prospect Analysis
10.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
10.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
10.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Country
10.6.1 Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10.6.2 United Kingdom Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10.6.3 France Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10.6.4 Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10.6.5 Spain Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
10.6.6 Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
11 ASIA-PACIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Country
11.6.1 China Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
11.6.2 Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
11.6.3 South Korea Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
11.6.4 Australia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
11.6.5 India Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
12 SOUTH AMERICA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS
12.1 Market Overview and Prospect Analysis
12.2 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
12.3 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
12.4 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Country
12.6.1 Brazil Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
12.6.2 Argentina Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
12.6.3 Columbia Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
13 MIDDLE EAST AND AFRICA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY MARKET ANALYSIS
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Analysis by Country
13.6.1 UAE Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
13.6.2 Egypt Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
13.6.3 South Africa Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate
14 CONCLUSIONS AND RECOMMENDATIONS
14.1 Key Market Findings and Prospects
14.2 Advice for Investors
15 APPENDIX
15.1 Methodology
15.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Product Picture
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate 2015-2025
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Key Market Segments
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) Segment by Type from 2015-2020
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Company Profile
Table Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Production and Growth Rate
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Market Revenue ($) Market Share 2015-2020
Table Celyad SA Company Profile
Table Celyad SA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Celyad SA Production and Growth Rate
Figure Celyad SA Market Revenue ($) Market Share 2015-2020
Table Celgene Corp. Company Profile
Table Celgene Corp. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Celgene Corp. Production and Growth Rate
Figure Celgene Corp. Market Revenue ($) Market Share 2015-2020
Table F. Hoffman La Roche AG Company Profile
Table F. Hoffman La Roche AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure F. Hoffman La Roche AG Production and Growth Rate
Figure F. Hoffman La Roche AG Market Revenue ($) Market Share 2015-2020
Table Transgene SA Company Profile
Table Transgene SA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Transgene SA Production and Growth Rate
Figure Transgene SA Market Revenue ($) Market Share 2015-2020
Table Juno Therapeutics Inc. (A Celgene Company) Company Profile
Table Juno Therapeutics Inc. (A Celgene Company) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Juno Therapeutics Inc. (A Celgene Company) Production and Growth Rate
Figure Juno Therapeutics Inc. (A Celgene Company) Market Revenue ($) Market Share 2015-2020
Table Shire Pharmaceuticals Inc. Company Profile
Table Shire Pharmaceuticals Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Shire Pharmaceuticals Inc. Production and Growth Rate
Figure Shire Pharmaceuticals Inc. Market Revenue ($) Market Share 2015-2020
Table Eureka Therapeutics Inc. Company Profile
Table Eureka Therapeutics Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Eureka Therapeutics Inc. Production and Growth Rate
Figure Eureka Therapeutics Inc. Market Revenue ($) Market Share 2015-2020
Table Cellectis Company Profile
Table Cellectis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Cellectis Production and Growth Rate
Figure Cellectis Market Revenue ($) Market Share 2015-2020
Table Formula Pharmaceuticals Inc. Company Profile
Table Formula Pharmaceuticals Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Formula Pharmaceuticals Inc. Production and Growth Rate
Figure Formula Pharmaceuticals Inc. Market Revenue ($) Market Share 2015-2020
Table Avacta Life Sciences Ltd. Company Profile
Table Avacta Life Sciences Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Avacta Life Sciences Ltd. Production and Growth Rate
Figure Avacta Life Sciences Ltd. Market Revenue ($) Market Share 2015-2020
Table Gilead Sciences Company Profile
Table Gilead Sciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Gilead Sciences Production and Growth Rate
Figure Gilead Sciences Market Revenue ($) Market Share 2015-2020
Table iCell Gene Therapeutics Company Profile
Table iCell Gene Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure iCell Gene Therapeutics Production and Growth Rate
Figure iCell Gene Therapeutics Market Revenue ($) Market Share 2015-2020
Table Bellicum Phamaceuticals Company Profile
Table Bellicum Phamaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bellicum Phamaceuticals Production and Growth Rate
Figure Bellicum Phamaceuticals Market Revenue ($) Market Share 2015-2020
Table Amgen Company Profile
Table Amgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amgen Production and Growth Rate
Figure Amgen Market Revenue ($) Market Share 2015-2020
Table Servier Laboratories Company Profile
Table Servier Laboratories Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Servier Laboratories Production and Growth Rate
Figure Servier Laboratories Market Revenue ($) Market Share 2015-2020
Table Noile-Immune Biotech Company Profile
Table Noile-Immune Biotech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Noile-Immune Biotech Production and Growth Rate
Figure Noile-Immune Biotech Market Revenue ($) Market Share 2015-2020
Table Puretech Health Company Profile
Table Puretech Health Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Puretech Health Production and Growth Rate
Figure Puretech Health Market Revenue ($) Market Share 2015-2020
Table Editas Medicine Inc. Company Profile
Table Editas Medicine Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Editas Medicine Inc. Production and Growth Rate
Figure Editas Medicine Inc. Market Revenue ($) Market Share 2015-2020
Table Medimmune Llc/Astrazeneca Company Profile
Table Medimmune Llc/Astrazeneca Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Medimmune Llc/Astrazeneca Production and Growth Rate
Figure Medimmune Llc/Astrazeneca Market Revenue ($) Market Share 2015-2020
Table Bluebird Bio Company Profile
Table Bluebird Bio Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bluebird Bio Production and Growth Rate
Figure Bluebird Bio Market Revenue ($) Market Share 2015-2020
Table Mustang Bio Inc. Company Profile
Table Mustang Bio Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Mustang Bio Inc. Production and Growth Rate
Figure Mustang Bio Inc. Market Revenue ($) Market Share 2015-2020
Table Novartis AG Company Profile
Table Novartis AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Market Revenue ($) Market Share 2015-2020
Table Protheragen Inc. Company Profile
Table Protheragen Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Protheragen Inc. Production and Growth Rate
Figure Protheragen Inc. Market Revenue ($) Market Share 2015-2020
Table Takeda Pharmaceuticals Company Profile
Table Takeda Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Takeda Pharmaceuticals Production and Growth Rate
Figure Takeda Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales by Types (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Share by Types (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue ($) by Types (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Share by Types (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price ($) by Types (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales by Types (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales Share by Types (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) by Types (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue Share by Types (2020-2025)
Figure Global Acute Lymphoblastic Leukemia (ALL) Sales and Growth Rate (2015-2020)
Figure Global Acute Lymphoblastic Leukemia (ALL) Price (2015-2020)
Figure Global Advanced Lymphomas Sales and Growth Rate (2015-2020)
Figure Global Advanced Lymphomas Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) and Growth Rate Forecast of Acute Lymphoblastic Leukemia (ALL) (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate Forecast of Acute Lymphoblastic Leukemia (ALL) (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) and Growth Rate Forecast of Advanced Lymphomas (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate Forecast of Advanced Lymphomas (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate Forecast of Others (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales by Applications (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Share by Applications (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue ($) by Applications (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Share by Applications (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales by Applications (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales Share by Applications (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Children Sales and Growth Rate (2015-2020)
Figure Global Children Price (2015-2020)
Figure Global Adult Sales and Growth Rate (2015-2020)
Figure Global Adult Price (2015-2020)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) and Growth Rate Forecast of Children (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate Forecast of Children (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) and Growth Rate Forecast of Adult (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate Forecast of Adult (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales by Regions (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Market Share by Regions (2015-2020)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Market Share by Regions in 2019
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Regions (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Regions (2015-2020)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Regions in 2019
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales by Regions (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales Share by Regions (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales (2020-2025)
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Canada Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales (2020-2025)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure France Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Spain Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales (2020-2025)
Figure Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure South Korea Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Gr
Figure Product Picture
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Size and Growth Rate 2015-2025
Table Chimeric Antigen Receptor (CAR) T-Cell Therapy Key Market Segments
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) Segment by Type from 2015-2020
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Chimeric Antigen Receptor (CAR) T-Cell Therapy
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Company Profile
Table Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Production and Growth Rate
Figure Kite Pharma Inc. (A Subsidiary of Gilead Sciences Inc.) Market Revenue ($) Market Share 2015-2020
Table Celyad SA Company Profile
Table Celyad SA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Celyad SA Production and Growth Rate
Figure Celyad SA Market Revenue ($) Market Share 2015-2020
Table Celgene Corp. Company Profile
Table Celgene Corp. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Celgene Corp. Production and Growth Rate
Figure Celgene Corp. Market Revenue ($) Market Share 2015-2020
Table F. Hoffman La Roche AG Company Profile
Table F. Hoffman La Roche AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure F. Hoffman La Roche AG Production and Growth Rate
Figure F. Hoffman La Roche AG Market Revenue ($) Market Share 2015-2020
Table Transgene SA Company Profile
Table Transgene SA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Transgene SA Production and Growth Rate
Figure Transgene SA Market Revenue ($) Market Share 2015-2020
Table Juno Therapeutics Inc. (A Celgene Company) Company Profile
Table Juno Therapeutics Inc. (A Celgene Company) Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Juno Therapeutics Inc. (A Celgene Company) Production and Growth Rate
Figure Juno Therapeutics Inc. (A Celgene Company) Market Revenue ($) Market Share 2015-2020
Table Shire Pharmaceuticals Inc. Company Profile
Table Shire Pharmaceuticals Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Shire Pharmaceuticals Inc. Production and Growth Rate
Figure Shire Pharmaceuticals Inc. Market Revenue ($) Market Share 2015-2020
Table Eureka Therapeutics Inc. Company Profile
Table Eureka Therapeutics Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Eureka Therapeutics Inc. Production and Growth Rate
Figure Eureka Therapeutics Inc. Market Revenue ($) Market Share 2015-2020
Table Cellectis Company Profile
Table Cellectis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Cellectis Production and Growth Rate
Figure Cellectis Market Revenue ($) Market Share 2015-2020
Table Formula Pharmaceuticals Inc. Company Profile
Table Formula Pharmaceuticals Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Formula Pharmaceuticals Inc. Production and Growth Rate
Figure Formula Pharmaceuticals Inc. Market Revenue ($) Market Share 2015-2020
Table Avacta Life Sciences Ltd. Company Profile
Table Avacta Life Sciences Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Avacta Life Sciences Ltd. Production and Growth Rate
Figure Avacta Life Sciences Ltd. Market Revenue ($) Market Share 2015-2020
Table Gilead Sciences Company Profile
Table Gilead Sciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Gilead Sciences Production and Growth Rate
Figure Gilead Sciences Market Revenue ($) Market Share 2015-2020
Table iCell Gene Therapeutics Company Profile
Table iCell Gene Therapeutics Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure iCell Gene Therapeutics Production and Growth Rate
Figure iCell Gene Therapeutics Market Revenue ($) Market Share 2015-2020
Table Bellicum Phamaceuticals Company Profile
Table Bellicum Phamaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bellicum Phamaceuticals Production and Growth Rate
Figure Bellicum Phamaceuticals Market Revenue ($) Market Share 2015-2020
Table Amgen Company Profile
Table Amgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amgen Production and Growth Rate
Figure Amgen Market Revenue ($) Market Share 2015-2020
Table Servier Laboratories Company Profile
Table Servier Laboratories Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Servier Laboratories Production and Growth Rate
Figure Servier Laboratories Market Revenue ($) Market Share 2015-2020
Table Noile-Immune Biotech Company Profile
Table Noile-Immune Biotech Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Noile-Immune Biotech Production and Growth Rate
Figure Noile-Immune Biotech Market Revenue ($) Market Share 2015-2020
Table Puretech Health Company Profile
Table Puretech Health Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Puretech Health Production and Growth Rate
Figure Puretech Health Market Revenue ($) Market Share 2015-2020
Table Editas Medicine Inc. Company Profile
Table Editas Medicine Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Editas Medicine Inc. Production and Growth Rate
Figure Editas Medicine Inc. Market Revenue ($) Market Share 2015-2020
Table Medimmune Llc/Astrazeneca Company Profile
Table Medimmune Llc/Astrazeneca Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Medimmune Llc/Astrazeneca Production and Growth Rate
Figure Medimmune Llc/Astrazeneca Market Revenue ($) Market Share 2015-2020
Table Bluebird Bio Company Profile
Table Bluebird Bio Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bluebird Bio Production and Growth Rate
Figure Bluebird Bio Market Revenue ($) Market Share 2015-2020
Table Mustang Bio Inc. Company Profile
Table Mustang Bio Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Mustang Bio Inc. Production and Growth Rate
Figure Mustang Bio Inc. Market Revenue ($) Market Share 2015-2020
Table Novartis AG Company Profile
Table Novartis AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Market Revenue ($) Market Share 2015-2020
Table Protheragen Inc. Company Profile
Table Protheragen Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Protheragen Inc. Production and Growth Rate
Figure Protheragen Inc. Market Revenue ($) Market Share 2015-2020
Table Takeda Pharmaceuticals Company Profile
Table Takeda Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Takeda Pharmaceuticals Production and Growth Rate
Figure Takeda Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales by Types (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Share by Types (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue ($) by Types (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Share by Types (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Price ($) by Types (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales by Types (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales Share by Types (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) by Types (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue Share by Types (2020-2025)
Figure Global Acute Lymphoblastic Leukemia (ALL) Sales and Growth Rate (2015-2020)
Figure Global Acute Lymphoblastic Leukemia (ALL) Price (2015-2020)
Figure Global Advanced Lymphomas Sales and Growth Rate (2015-2020)
Figure Global Advanced Lymphomas Price (2015-2020)
Figure Global Others Sales and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) and Growth Rate Forecast of Acute Lymphoblastic Leukemia (ALL) (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate Forecast of Acute Lymphoblastic Leukemia (ALL) (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) and Growth Rate Forecast of Advanced Lymphomas (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate Forecast of Advanced Lymphomas (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate Forecast of Others (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales by Applications (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Share by Applications (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue ($) by Applications (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Share by Applications (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales by Applications (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales Share by Applications (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Children Sales and Growth Rate (2015-2020)
Figure Global Children Price (2015-2020)
Figure Global Adult Sales and Growth Rate (2015-2020)
Figure Global Adult Price (2015-2020)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) and Growth Rate Forecast of Children (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate Forecast of Children (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue ($) and Growth Rate Forecast of Adult (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate Forecast of Adult (2020-2025)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales and Growth Rate (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales by Regions (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Market Share by Regions (2015-2020)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Sales Market Share by Regions in 2019
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue and Growth Rate (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue by Regions (2015-2020)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Regions (2015-2020)
Figure Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Revenue Market Share by Regions in 2019
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales by Regions (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales Share by Regions (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales (2020-2025)
Figure North America Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Canada Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Mexico Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales (2020-2025)
Figure Europe Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure France Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Italy Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Spain Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Russia Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Sales (2020-2025)
Figure Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure Japan Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Growth Rate (2015-2020)
Figure South Korea Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Sales and Gr
